Skip to content

Marouane Nassim

4 papers in the library · 27 citations · publishing 2019-2021

Papers

Sort Most recent Most cited

Do Brief Mindfulness Interventions (BMI) and Health Enhancement Programs (HEP) Improve Sleep in Patients in Hemodialysis with Depression and Anxiety?

Healthcare October 21, 2021 Paola Lavín, Rim Nazar, Marouane Nassim et al. 7 citations

(1) Objective: to determine if a brief mindfulness intervention (BMI) and a health education program (HEP) could improve measures of insomnia in patients undergoing hemodialysis. (2) Methods: this was a planned secondary analysis of a randomized controlled trial of BMI vs. HEP for hemodialysis patients with depression and/or anxiety symptoms. The primary outcome for the analysis was the Athens...

Brief Mindfulness Intervention vs. Health Enhancement Program for Patients Undergoing Dialysis: A Randomized Controlled Trial

Healthcare June 1, 2021 Marouane Nassim, Haley Park, Elena Dikaios et al. 20 citations

BACKGROUND: Between 20-50% of patients undergoing maintenance dialysis for end-stage kidney disease experience symptoms of depression and/or anxiety, associated with increased mortality, greater health care utilization, and decreased quality of life. It is unknown whether mindfulness-based interventions can improve depression and anxiety symptoms in patients receiving this treatment. METHODS:...

Continuation Sessions of Mindfulness‐Based Cognitive Therapy (MBCT‐C) vs. Treatment as Usual in Late‐Life Depression and Anxiety: An Open‐Label Extension Study

International Journal of Geriatric Psychiatry June 11, 2020 Elena Dikaios, Sophia Escobar, Marouane Nassim et al.

Mindfulness‐based cognitive therapy (MBCT) is a novel treatment for depression. Our published randomized controlled trial shows that MBCT improves symptoms of late‐life depression (LLD) and anxiety (LLA). We now examine whether continuation sessions of MBCT (MBCT‐C) can prevent LLD/LLA symptom recurrence.

Sahaj Samadhi meditation vs a Health Enhancement Program in improving late-life depression severity and executive function: study protocol for a two-site, randomized controlled trial

Trials October 24, 2019 S. B. Peckham, Emily Ionson, Marouane Nassim et al.

BackgroundRecent estimates suggest an 11% prevalence of current late-life depression (LLD) and a lifetime prevalence of 16–20%. LLD leads to cognitive disturbance as well as a nearly two to three times increased risk of dementia. We conducted a recent randomized controlled trial (RCT) which demonstrated that Sahaj Samadhi meditation (SSM), an easy-to-implement, meditation-based augmentation...